Pharmacokinetics of adamantane-derived actoprotectors: Bromitil experiments
Animal research · 1995
- What was studied
- Experimental pharmacokinetic program; rat studies
- Main finding
- The dissertation contents and reproduced conclusions identify a Bromitil pharmacokinetic section. The formulation is discussed as combined Bromantane and Bemitil.
Study data at a glance
- Participants or experimental model
- Experimental pharmacokinetic program; rat studies
- Reported results
- The dissertation contents and reproduced conclusions identify a Bromitil pharmacokinetic section. The formulation is discussed as combined Bromantane and Bemitil.
Study limitations and source details
Study limitations
- Transcription is not a verified original scan.
- Pharmacokinetic interaction does not demonstrate clinical synergy or combination safety.
- Exact formulation and experiment-level denominators require the original methods.
Source details
Dissertation transcription · Dissertation excerpt transcription
Third-party transcription of original dissertation contents and conclusions checked; complete 162-page dissertation not recovered.
Contents and reproduced conclusions
Sources checked
Citation
L. M. Krasnykh. Pharmacokinetics of adamantane-derived actoprotectors: Bromitil experiments Candidate dissertation, Kupavna, 1995
Related compounds
Bromitil
A historical combination tablet containing Bromantane and Bemitil, described in animal drug-distribution research.
Bromantane
A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.
Bemitil
A synthetic benzimidazole derivative also called bemethyl or Metaprot. Soviet and Russian researchers studied it as an actoprotector, a drug intended to preserve physical work capacity under stress.